Detalles de la búsqueda
1.
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.
J Exp Clin Cancer Res
; 43(1): 75, 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38459559
2.
Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available.
J Clin Pathol
; 75(12): 844-850, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34400544
3.
A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting.
Cancers (Basel)
; 14(12)2022 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740637
Resultados
1 -
3
de 3
1
Próxima >
>>